# Infranodal Conduction Time During TAVR as Predictor of HAVB

> **NCT04128384** · NA · UNKNOWN · sponsor: **University Hospital, Saarland** · enrollment: 200 (estimated)

## Conditions studied

- Severe Aortic Valve Stenosis
- High-degree AV Block
- Left Bundle-Branch Block

## Interventions

- **DIAGNOSTIC_TEST:** Limited electrophysiologic study including measurements of HV- and AH-intervals pre- and post-TAVR

## Key facts

- **NCT ID:** NCT04128384
- **Lead sponsor:** University Hospital, Saarland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-21
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04128384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04128384, "Infranodal Conduction Time During TAVR as Predictor of HAVB". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04128384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*